UNSPSC 51144126: Levamfetamine succinate

This classification denotes a cns stimulant with the molecular formula C9H13N.C4H6O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier STC9O9MD79, chemically known as butanedioic acid, compd. with (-)-alpha-methylbenzeneethanamine (1:1) but more generally known as levamfetamine succinate, which bears US NIH Compound Identifier 68638. Most nations, for tariff and trade purposes, schedule levamfetamine succinate under HS 29214900 and SITC 51454. As of Q4 2014, LEVAMFETAMINE SUCCINATE remains US FDA's Preferred Term for this commodity.

SMILES: C[C@H](CC1CCCCC1)N.C(CC(=O)O)C(=O)O.

UNSPSC 51144126 Levamfetamine succinate is a Commodity code that does not align with recent state and local solicitation activity. The single recent opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023—calls for procurement of naloxone and safe drug deactivation systems for community health support, neither of which is levamfetamine succinate. The mismatch suggests either a coding error in the county's tagging or a systemic misalignment between the code's pharmaceutical scope and actual procurement use by state and local health agencies.

The code shows insufficient recent activity to support a meaningful business development assessment. Levamfetamine succinate, a prescription stimulant, does not appear in current state and local government solicitations tracked in accessible procurement databases. If your firm pursues opportunities in this therapeutic category, monitor health department RFPs and pharmaceutical supply contracts directly rather than relying on this code's activity signal.